Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Two of today's biggest analyst moves point in opposite directions. Truist raised its price target on GOOGL to $430, reaffirming Buy as AI-driven traffic growth keeps Alphabet firmly in favour. Piper Sandler went further on DELL, lifting its target to $497 — nearly tripling the prior figure — and upgrading the stock on the back of AI infrastructure demand. Meanwhile, Truist cut CZR to Hold with a $31 target, flagging consumer spending concerns in leisure.
MNKD scored a significant win today. The FDA approved Afrezza — its inhaled insulin — for children aged 6 and older. It's the first inhaled mealtime insulin cleared for pediatric use. Short interest sits at 10.1% of free float. Options depth is thin relative to the news scale, which could create rapid repricing.
Short pressure remains extreme on WOLF, where bears hold 131% of free float — up 20 points in a week. Shares to borrow have run dry. On the insider front, large sell filings dominated the week. Twilio saw a $184M block sale filed by a board-linked fund manager. The Walton family trimmed $251M in WMT stock. Ralph Lauren's founder sold $99.7M in RL shares. On the buy side, Capital Group disclosed a $285M purchase of ONC.
Retail dominates next week's earnings calendar. ULTA, DG, MDT, and M all report. Consumer spending signals from these names will set the tone heading into June.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
